Glioblastoma Clinical Trials
Glioblastoma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for glioblastoma. Corterve aggregates actively recruiting Glioblastoma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Glioblastoma studies
- Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBMNCT04991870PHASE1M.D. Anderson Cancer CenterHouston, Texas
- A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB TrialNCT06069726PHASE2Duke UniversitySan Francisco, California
- PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN AmplificationsNCT06161519PHASE1, PHASE2National Cancer Institute (NCI)Bethesda, Maryland
- A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBMNCT05303467PHASE1Boston Scientific CorporationBirmingham, Alabama
- Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and RelatlimabNCT06816927PHASE2Duke UniversityDurham, North Carolina
- HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsNCT03911388PHASE1M.D. Anderson Cancer CenterBirmingham, Alabama
- Phase I Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Solid Tumors Like GBM and PDACNCT07733674PHASE1Radiomedix, Inc.Houston, Texas
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaNCT03970447PHASE2, PHASE3Global Coalition for Adaptive ResearchBirmingham, Alabama
- Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBMNCT05902169PHASE3CarTheraPhoenix, Arizona
- Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaNCT06860594PHASE1National Cancer Institute (NCI)Duarte, California
- A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade GliomaNCT07464925PHASE1Tetragon Biosciences LtdTampa, Florida
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasNCT07285044PHASE2Mayo ClinicJacksonville, Florida
Glioblastoma trials by state
Glioblastoma trials by metro
Frequently asked questions
- How do I find recruiting Glioblastoma clinical trials?
- Corterve aggregates actively recruiting Glioblastoma studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Glioblastoma clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Glioblastoma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.